Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

FDA Drug Application 201292 by BOEHRINGER INGELHEIM

Application Number201292
Application Type New Drug Application
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan CodeV

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP07/12/2013N36785000 8/15/2013
AP07/12/2013N36786000 8/15/2013
AP07/12/2013N36538000 7/12/2013
AP07/12/2013N36541000 7/12/2013
AP07/23/2013SLR36607001 7/26/2013
AP07/23/2013SLR36662001 7/30/2013
AP07/23/2013SLR37529001 10/23/2013
AP011/21/2013SLR37886002 11/22/2013
AP011/21/2013SLR37904002 11/25/2013
AP011/9/2015SE844446006 11/12/2015
AP011/9/2015SE844471006 11/13/2015
AP04/15/2016SE845694007 4/18/2016
AP04/15/2016SE845699007 4/19/2016
AP012/28/2015SLR44903008 12/29/2015
AP012/28/2015SLR44925008 12/31/2015
AP04/20/2016SLR45713009 4/22/2016
AP04/20/2016SLR45780009 4/27/2016
AP010/4/2016SLR47289010 10/6/2016
AP010/4/2016SLR47295010 10/6/2016

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.